Project will use big data and analytics to address pressing public health issue
Bettis unveils new playbook for defending against severe allergic reactions and affected to take action
First patient enrolled in Phase III clinical trial for moxetumomab pasudotox as a treatment for unresponsive or relapsed hairy cell leukemia patients
Simponi has already been approved by the FDA for the treatment of moderately to severely active rheumatoid arthritis
Like a game of whack-a-mole, no matter how many times Johnson & Johnson attempts to put to rest lawsuits over the marketing of its Risperdal...
Another fascinating day comes to an end. Tomorrow will, no doubt, prove just as interesting. Now, Pharmalot must run to the voting booth. Democracy beckons. Meanwhile, here are a few interesting items to help you unwind....
The Gates Foundation Challenges Big Pharma;
For-proft Dialysis Chains Love Anemia Drugs;
